跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,938 条关于
“NSD2 inhibitor”
全部
19,938
临床试验
9,789
药物
4,076
机构
20
资讯
6,053
去年
NSD2 Overexpression in Multiple Myeloma May Drive Immune Evasion, New Research Suggests
9个月前
First-in-Class MMSET Inhibitor Gintemetostat Shows Clinical Activity in Heavily Pretreated Multiple Myeloma
去年
Gilteritinib Shows Promise as ALK Inhibitor in Acute Myeloid Leukemia
2年前
Merck's Bomedemstat Shows Promise as Irreversible LSD1 Inhibitor for MPNs
2年前
FDA Approves Resmetirom (REZDIFFRA™) as First Treatment for NASH
9个月前
Dizal Reports Promising Hematology Data at ASH 2025 with JAK1 Inhibitor Golidocitinib and Dual BTK/LYN Inhibitor Birelentinib
5年前
Comparative Analysis of PARP Inhibitors in BRCA-Mutated Ovarian Cancer Shows Similar Efficacy and Toxicity
6年前
PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies
2年前
BridgeBio's BBO-8520: A Novel KRAS(G12C) Inhibitor Shows Promise in NSCLC
去年
KRAS Inhibitor Market to Reach $186.4 Million by 2033, Driven by Targeted Cancer Therapies
第 1 页,共 606 页
上一页
下一页